Immunogenetics
January 2025
Unlike other mammals, bats serve as natural reservoirs for several highly pathogenic viruses without exhibiting symptoms of infection. Recent research has explored the complex mechanisms underlying the balance between bats' antiviral defenses and their pathological responses. However, the evolution of the molecular drivers behind bats' antiviral strategies remains largely unknown.
View Article and Find Full Text PDFOptical density measurement has been used for decades to determine the microorganism concentration and more rarely for mammalian cells. Although this measurement can be carried out at any wavelength, studies report a limited number of measurement wavelengths, mainly around 600 nm, and no consensus seems to be emerging to propose an objective method for determining the optimum measurement wavelength for each microorganism. In this article, we propose a method for analyzing the absorbance spectra of ESKAPEE bacteria and determining the optimum measurement wavelength for each of them.
View Article and Find Full Text PDFLittle is known about the epidemiology of leptospirosis in the Dominican Republic, the second most populous country in the Caribbean. We report on findings from a multi-stage household survey across two regions in the country that reveals a previously under-estimated burden of human Leptospira infection. Our findings, based on the reference-standard microscopic agglutination test, indicate a complex picture of serogroup diversity, spatial heterogeneity in infection and risk, and a marked discrepancy between reported cases and serologically estimated infections.
View Article and Find Full Text PDFBackground: To determine the sociodemographic factors associated with knowledge and adequate attitudes about HIV in women of reproductive age from Peru in 2021.
Materials And Methods: Analytical cross-sectional study. We analyzed a demographic and family health survey (ENDES) 2021 carried out in women of reproductive age (12 to 49 years of age).
The treatment landscape for IgA nephropathy (IgAN) is rapidly evolving with the introduction of novel therapies targeting diverse disease pathways. Some have already been approved in different countries, while others are under investigation in randomized controlled trials (RCTs) with encouraging results. However, almost all performed RCTs have included only patients with refractory non-nephrotic proteinuria and preserved renal function.
View Article and Find Full Text PDF